多柔比星脂质体与表柔比星在HER-2阴性乳腺癌术后辅助化疗中的比较
Comparison of doxorubicin liposome and epirubicin in adjuvant chemotherapy after HER-2 negative breast cancer surgery
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |